Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Dive
preface
classgrid-row grid-gap
Dive
classgrid-col-12

Span
classcaption

Dr. John Finlayson’s Diethylaminoethyl cellulose column inside the cold room in Building 8 before being moved to Building 29, 1st floor.  Diethylaminoethyl  cellulose is a positively charged resin that was used in ion-exchange chromatography.

Span
classcredit

CreditFInlayson Photo Collection at the Office of NIH History & Stetten Museum

Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine

...

Dive
preface
classgrid-row grid-gap
Dive
classgrid-col-12

Vaccine vial and box

Span
classcaption

SmithKline Beecham Biologicals Hepatitis A Vaccine, Harvix, adolescent dose. NIAID’s Drs. Robert H. Purcell, Suzanne U. Emerson, and Jeffrey I. Cohen, and the FDA’s Drs. Stephen Feinstone and Richard Daemer of the Center for Biologics Evaluation and Research, developed and patented a hepatitis A virus (HAV) and related technology used to develop the vaccine. 

Span
classcredit

Office of NIH History & Stetten Museum

...

Syringes

Dive
preface
classgrid-row grid-gap
Dive
classgrid-col-12

Span
classcaption

Becton, Dickinson & Co. Yale Luer-Lok 100 cc Syringe from between 1953 and 1970. In 1934, BD introduced the BD Yale Luer-Lok™ Syringe, designed and patented by Fairleigh S. Dickinson, Sr. It provided a simple, secure method of attaching and removing a needle to and from a syringe. Today, Luer-Lok connectors are the standard for syringes in the United States. 

Span
classcredit

Office of NIH History & Stetten Museum

...